166 related articles for article (PubMed ID: 11799083)
1. Dominant negative mutant of c-Jun inhibits cardiomyocyte hypertrophy induced by endothelin 1 and phenylephrine.
Omura T; Yoshiyama M; Yoshida K; Nakamura Y; Kim S; Iwao H; Takeuchi K; Yoshikawa J
Hypertension; 2002 Jan; 39(1):81-6. PubMed ID: 11799083
[TBL] [Abstract][Full Text] [Related]
2. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
[TBL] [Abstract][Full Text] [Related]
3. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the rat atrial natriuretic peptide gene after acute imposition of left ventricular pressure overload.
Cornelius T; Holmer SR; Müller FU; Riegger GA; Schunkert H
Hypertension; 1997 Dec; 30(6):1348-55. PubMed ID: 9403552
[TBL] [Abstract][Full Text] [Related]
5. The mixed-lineage kinase 1-3 signalling pathway regulates stress response in cardiac myocytes via GATA-4 and AP-1 transcription factors.
Ola A; Kerkelä R; Tokola H; Pikkarainen S; Skoumal R; Vuolteenaho O; Ruskoaho H
Br J Pharmacol; 2010 Feb; 159(3):717-25. PubMed ID: 20067472
[TBL] [Abstract][Full Text] [Related]
6. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload.
Nakagawa O; Ogawa Y; Itoh H; Suga S; Komatsu Y; Kishimoto I; Nishino K; Yoshimasa T; Nakao K
J Clin Invest; 1995 Sep; 96(3):1280-7. PubMed ID: 7657802
[TBL] [Abstract][Full Text] [Related]
7. Extracellular ATP inhibits adrenergic agonist-induced hypertrophy of neonatal cardiac myocytes.
Zheng JS; Boluyt MO; Long X; O'Neill L; Lakatta EG; Crow MT
Circ Res; 1996 Apr; 78(4):525-35. PubMed ID: 8635209
[TBL] [Abstract][Full Text] [Related]
8. Prevention of hypertrophy by overexpression of Kv4.2 in cultured neonatal cardiomyocytes.
Zobel C; Kassiri Z; Nguyen TT; Meng Y; Backx PH
Circulation; 2002 Oct; 106(18):2385-91. PubMed ID: 12403671
[TBL] [Abstract][Full Text] [Related]
9. Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor.
Thomas WG; Brandenburger Y; Autelitano DJ; Pham T; Qian H; Hannan RD
Circ Res; 2002 Feb; 90(2):135-42. PubMed ID: 11834705
[TBL] [Abstract][Full Text] [Related]
10. c-Jun N-terminal kinase-interacting protein 1 inhibits gene expression in response to hypertrophic agonists in neonatal rat ventricular myocytes.
Finn SG; Dickens M; Fuller SJ
Biochem J; 2001 Sep; 358(Pt 2):489-95. PubMed ID: 11513749
[TBL] [Abstract][Full Text] [Related]
11. DY-9760e inhibits endothelin-1-induced cardiomyocyte hypertrophy through inhibition of CaMKII and ERK activities.
Lu YM; Shioda N; Han F; Kamata A; Shirasaki Y; Qin ZH; Fukunaga K
Cardiovasc Ther; 2009; 27(1):17-27. PubMed ID: 19207476
[TBL] [Abstract][Full Text] [Related]
12. Phenylephrine, endothelin, prostaglandin F2alpha' and leukemia inhibitory factor induce different cardiac hypertrophy phenotypes in vitro.
King KL; Winer J; Phillips DM; Quach J; Williams PM; Mather JP
Endocrine; 1998 Aug; 9(1):45-55. PubMed ID: 9798730
[TBL] [Abstract][Full Text] [Related]
13. Adrenomedullin is a regulated modulator of neonatal cardiomyocyte hypertrophy in vitro.
Autelitano DJ; Ridings R; Tang F
Cardiovasc Res; 2001 Aug; 51(2):255-64. PubMed ID: 11470465
[TBL] [Abstract][Full Text] [Related]
14. Effects of adrenomedullin on hypertrophic responses induced by angiotensin II, endothelin-1 and phenylephrine.
Luodonpää M; Vuolteenaho O; Eskelinen S; Ruskoaho H
Peptides; 2001 Nov; 22(11):1859-66. PubMed ID: 11754973
[TBL] [Abstract][Full Text] [Related]
15. Dominant-negative c-Jun inhibits rat cardiac hypertrophy induced by angiotensin II and hypertension.
Kim-Mitsuyama S; Izumi Y; Izumiya Y; Namba M; Yoshida K; Wake R; Yoshiyama M; Iwao H
Gene Ther; 2006 Feb; 13(4):348-55. PubMed ID: 16251994
[TBL] [Abstract][Full Text] [Related]
16. Eicosapentaenoic acid prevents endothelin-1-induced cardiomyocyte hypertrophy in vitro through the suppression of TGF-beta 1 and phosphorylated JNK.
Shimojo N; Jesmin S; Zaedi S; Maeda S; Soma M; Aonuma K; Yamaguchi I; Miyauchi T
Am J Physiol Heart Circ Physiol; 2006 Aug; 291(2):H835-45. PubMed ID: 16501010
[TBL] [Abstract][Full Text] [Related]
17. Chronic activation of extracellular-signal-regulated protein kinases by phenylephrine is required to elicit a hypertrophic response in cardiac myocytes.
Barron AJ; Finn SG; Fuller SJ
Biochem J; 2003 Apr; 371(Pt 1):71-9. PubMed ID: 12513686
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated overexpression of diacylglycerol kinase-zeta inhibits endothelin-1-induced cardiomyocyte hypertrophy.
Takahashi H; Takeishi Y; Seidler T; Arimoto T; Akiyama H; Hozumi Y; Koyama Y; Shishido T; Tsunoda Y; Niizeki T; Nozaki N; Abe J; Hasenfuss G; Goto K; Kubota I
Circulation; 2005 Mar; 111(12):1510-6. PubMed ID: 15781737
[TBL] [Abstract][Full Text] [Related]
19. Rheb activates protein synthesis and growth in adult rat ventricular cardiomyocytes.
Wang Y; Huang BP; Luciani DS; Wang X; Johnson JD; Proud CG
J Mol Cell Cardiol; 2008 Dec; 45(6):812-20. PubMed ID: 18722381
[TBL] [Abstract][Full Text] [Related]
20. [Changes of c-fos, c-jun mRNA expressions in cardiomyocyte hypertrophy induced by angiotensin II and effects of tanshinone II A].
Zhou DX; Liang QS; He XX; Zhan CY
Zhongguo Zhong Yao Za Zhi; 2008 Apr; 33(8):936-9. PubMed ID: 18619357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
